sciencelife.uchospitals.edu
Study adds diabetes drug to current state-of-the-art therapy for patients with ovarian cancer
The University of Chicago Medicine is leading a clinical trial that will add metformin, a drug commonly used for type II diabetes, to the most effective current therapy for patients with stage 3 or…